The presentation session will allow participants to engage in a Q&A segment regarding the company's recent activity. Those wishing to follow the event live can access the broadcast through the official Sobi website, where slide materials will be published ahead of the call. International participants may connect via dedicated dial-in lines, including +46 8 5051 0031 for Sweden, +44 203 059 58 63 for the United Kingdom, and +1 631 570 56 13 for the United States. Following the event, a recording will remain available on the company’s investor portal.
Sobi schedules second quarter 2026 financial results
Stockholm-based biopharmaceutical firm Sobi will release its financial performance report for the second quarter of 2026 on July 16 at 08:00 CEST. The company has organized a conference call for investors, analysts, and media members to review these results later that same day at 14:00 CEST.
Comments (0)
No comments yet. Be the first!